Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|January 5, 2002
Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanolsJean-Louis Peglion, Bertrand Goument, Nicole Despaux, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 29, 2008
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agentsMauricette Brocco, Anne Dekeyne, Clotilde Mannoury la Cour, et al.
Bioorganic & Medicinal Chemistry|December 29, 2016
Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT<sub>6</sub> receptor ligands with significant selectivity for D<sub>3</sub> over D<sub>2</sub> receptorsOscar M Saavedra, Delphine Karila, Dominique Brossard, et al.
Frontiers in Pharmacology|March 17, 2018
Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-PhenylethylamineXiaoqun Zhang, Ioannis Mantas, Alexandra Alvarsson, et al.
Journal of Pineal Research|March 17, 2025
Orphan GPR50 Restrains Neurite Outgrowth and Cell Migration by Activating the G<sub>12/13</sub> Protein-RhoA Pathway in Neural Progenitor Cells and TanycytesRaise Ahmad, Marine Luka, Anne-Sophie Journe, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptorsMark J Millan, Clotilde Mannoury la Cour, Francesca Novi, et al.
Neuropharmacology|January 13, 2009
The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in ratsXiao-Qing Peng, Charles R Ashby, Krista Spiller, et al.
Neural Plasticity|March 14, 2018
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR SignalingGinetta Collo, Laura Cavalleri, Federica Bono, et al.
The International Journal of Neuropsychopharmacology|July 29, 2010
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate proceduresMark J Millan, Jerry J Buccafusco, Florence Loiseau, et al.
Acta Neuropathologica Communications|November 3, 2021
P62 accumulates through neuroanatomical circuits in response to tauopathy propagationFrançois-Xavier Blaudin de Thé, Benjamin Lassus, Ari W Schaler, et al.
Pageof 19